新朋股份(002328.SZ):瀚娛動擬2.5億元參與設立南京吉祥基金
格隆匯12月7日丨新朋股份(002328.SZ)公佈,為進一步實現新朋股份新興產業的戰略佈局,公司擬與江蘇新潮科技集團有限公司(以下簡稱“新潮集團”)在半導體、新興產業領域進行合作。新朋股份董事會決定以全資子公司瀚娛動作為有限合夥人認購金浦新潮擬設立並管理的南京金浦新潮吉祥創業投資合夥企業(有限合夥)(暫定名)(以下簡稱“南京吉祥基金”)的基金份額。
基金規模暫定為8億元,瀚娛動擬利用自有資金出資2.5億元認購不超過35%的南京吉祥基金份額。金浦新潮投資管理(上海)有限公司(以下簡稱“金浦新潮”)擬為基金管理人。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.